Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3,203,885
-
Total 13F shares
-
2,296,843
-
Share change
-
-126,177
-
Total reported value
-
$141,225,482
-
Price per share
-
$61.47
-
Number of holders
-
112
-
Value change
-
-$8,017,331
-
Number of buys
-
56
-
Number of sells
-
52
Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q4 2024
As of 31 Dec 2024,
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,296,843 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, BlackRock, Inc., BRANDES INVESTMENT PARTNERS, LP, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, Ranger Investment Management, L.P., STATE STREET CORP, and JPMORGAN CHASE & CO.
This page lists
112
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.